Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly NeoRecormon in chemotherapy-associated anemia in adults with solid tumors
2005-004189-17Phase 4Completed
- Sponsor
- Roche
- Start
- Nov 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of epoetin beta in anaemia, sponsored by Roche. Primary endpoints: Overall incidence of patients reporting adverse events after study medication start, Hematology and blood chemistry monitoring and 1 more. Started Nov 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
anaemia
Beyond the preview
Go deeper on 2005-004189-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004189-17.